3-(3,5-Dibromophenyl)-9-phenyl-9H-carbazole, 98%, 100mg

Acétate de 3-méthoxy-3-méthylbutyle, min 98 %, pour la synthèse, 500 ml, emballage en verre

2-Bromo-4-thiazolecarboxylic acid, 97.0%, 500g

Ethyl 6-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride, 95.0%, 1g

5-Aminoquinoxaline, 97.0%, 250mg

1,1,1-Trichloro-2-methyl-2-propanol Hemihydrate, 98.0%, 25g

tert-Butyl 6-chloro-3-formylpyridin-2-ylcarbamate, 95.0%, 1g

2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid, 98%, 5g

3-Ethyl-2-methylpentane>99.0%(GC)5mL

2-Ethoxy-5-fluoropyridine, 95.0%, 5g

(3S)-1-{[3-(aminomethyl)-1,2,4-oxadiazol-5-yl]carbonyl}pyrrolidin-3-ol, 95.0%, 1g

5-Bromo-4-chloropyridine-2,3-diamine, 95.0%, 100mg

(R)-tert-Butyl 2-(1,3-dioxoisoindolin-2-yloxy)-4-methylpentanoate, 98%, 1g